GlassScriptPhysician profile
Douglas Kelly
NPI 1497716781
$3,417.24
in general payments reported to CMS, 2019-2025
24 companies · $408 in 2025
The $408 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $17.35 · 2021: $1,601 · 2022: $240 · 2023: $312 · 2024: $264 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $984.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $984.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accuray Incorporated | $1,520.75 | 2021 | |
| Boston Scientific Corporation | $401.83 | 2019-2025 | Spaceoar Vue System - 10ml |
| Siemens Medical Solutions USA, INC. | $278.80 | 2021-2023 | Halcyon |
| Janssen Biotech, INC. | $197.46 | 2019-2023 | Erleada |
| Elekta, INC. | $151.00 | 2025 | |
| Novartis Pharmaceuticals Corporation | $144.70 | 2019-2022 | |
| Pfizer INC. | $129.97 | 2019-2025 | |
| Progenics Pharmaceuticals, INC. | $112.49 | 2022 | |
| Histosonics, INC. | $94.05 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $85.83 | 2019-2024 | Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $55.83 | 2019-2020 | |
| Celgene Corporation | $30.36 | 2019 | |
| Abbvie INC. | $27.03 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.55 | 2019 | |
| Varian Medical Systems, INC. | $20.20 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $18.61 | 2019 | |
| Blue Earth Diagnostics | $18.45 | 2019 | |
| Novocure INC. | $18.16 | 2019 | |
| Sobi, INC | $17.42 | 2024 | |
| Genzyme Corporation | $17.03 | 2019 | |
| Array Biopharma INC | $16.08 | 2019 | |
| Genentech USA, INC. | $14.54 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.43 | 2019 | |
| Amgen INC. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.